Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05543018
Other study ID # RC-10-22
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 12, 2022
Est. completion date October 28, 2023

Study information

Verified date September 2022
Source Benha University
Contact Ahmed A Tabl, MD
Phone 01222328766
Email ahmad4lg@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intraocular tamponade used in vitrectomy operations may affects retinal function in various mechanisms.


Description:

Various intraocular tamponade are being used in vitrectomy operations as gases, fluids and silicon oil. The effects of these intraocular tamponade may affects the final visual outcome of the surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 28, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - primary retinal detachment patients. - patients eligible for 23 gauge pars-plana vitrectomy operation. Exclusion Criteria: - patients with axial length more than 30 millimeter that may have severe chorioretinal degenerations that may affects retinal function. - patients with macular diseases that may affects final visual outcome as macular holes and choroidal neovascular membranes.

Study Design


Intervention

Diagnostic Test:
Electroretinogram
Retinal function assessment using electroretinogram
Procedure:
Vitrectomy operation
Vitrectomy operation to treat retinal detachment

Locations

Country Name City State
Egypt Ahmed Abdelshafy Tabl Banha Benha

Sponsors (1)

Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual acuity Changes in visual acuity measured in LogMAR units. Baseline and monthly after surgery till 6 months of follow up.
Primary Retinal function amplitude Changes in electroretinogram amplitude parameters in microvolt/second measured by roland consult retinal function device. Baseline and monthly after surgery till 6 months of follow up.
Primary Retinal function implicit time. Changes in electroretinogram implicit time in millisecond measured by roland consult retinal function device. Baseline and monthly after surgery till 6 months of follow up.
Secondary Intraocular pressure Changes in intraocular pressure measured by goldman applanation tonometry in millimeter mercury. Baseline and monthly after surgery till 6 months of follow up.
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A